EVscale Archives - Tamirna - stability for life

9 01, 2025

TAmiRNA ‘2024 In Review’

2025-01-09T14:05:02+01:00January 9th, 2025|biomarker, Biomarker Discovery, biomarkers, CE-IVD, congress, EVscale, exosomes, extracellular vesicle, hepatomiR kit, Illumina NewSeq2000, ISO 13485, liquid biopsies, Liver disease, microRNA, microRNA services, microRNAs, NGS, PCR testing service, quality, sequencing, small RNA-sequencing, smallRNA, test service|Comments Off on TAmiRNA ‘2024 In Review’

2024: A Year of Growth, Innovation, and Collaboration 2024 has come to a close. We are proud to reflect on the milestones and achievements we’ve reached together with our incredible team, customers, partners, and supporters. Here’s a look back at what we accomplished this year: 👩‍🔬 Team Expansion Welcomed 3 talented new members to our growing team. 🏥 Diagnostic Implementation Successfully rolled out our CE-IVD microRNA liver function test in 5+ clinics, advancing molecular diagnostics. ✅ Service Excellence Completed over 80 RNA service projects, achieving 100% customer satisfaction. 🛠 Bioinformatics Innovation Developed 2 new pipelines: isomiR analysis and tRNA analysis, enhancing our capabilities. 🧬 Expanded Service Offerings Added whole-transcriptome sequencing for mRNA, lncRNA, and circRNA in liquid biopsies to our service portfolio. [...]

TAmiRNA at Precision EV Forum in Cambridge

2024-10-17T12:39:26+02:00October 17th, 2024|biomarker, biomarkers, Evercyte, EVscale, microRNAs, NGS, small RNA-sequencing|Comments Off on TAmiRNA at Precision EV Forum in Cambridge

Excited to share that TAmiRNA and Evercyte will join forces at the upcoming Precision EV Forum in Cambridge! 🚀 As key members of the EVscale® consortium, they’ll be showcasing cutting-edge solutions in EV (extracellular vesicles) characterization and therapeutics. TAmiRNA will present its advanced multiomic capabilities for RNA cargo characterization, aiding in biomarker discovery. Evercyte will highlight its clinical-grade EVs produced from telomerized MSCs, demonstrating the potential of EV therapeutics. Together with Phoenestra's bioreactor technology, these innovations support faster, scalable EV production. 🌱🧬 Catch us at Cripps Court Conference Centre and discover our vision for the future of EV-based precision medicine! 💡🔬 Meet us at the Precision EV Forum or reach out to info@tamirna.com to discuss our latest [...]

TAmiRNA at ASEV/CzeSEV meeting

2024-09-11T14:41:44+02:00September 11th, 2024|biomarker, biomarkers, Evercyte, EVscale, microRNAs, NGS, Phoenestra, small RNA-sequencing|Comments Off on TAmiRNA at ASEV/CzeSEV meeting

TAmiRNA, Evercyte and Phoenestra, three leading biotech companies, will present their cutting-edge work in for production and characterization of clinical-grade extracellular vesicles (EVs) at the upcoming shared Annual Meeting of the Austrian and Czechia Societies for Extracellular Vesicles (ASEV & CzeSEV) on 16th/17th September in Vienna. As esteemed ASEV members, TAmiRNA and Evercyte are well-known participants at these meetings and this year will take the spotlight as Platinum Sponsors. They will be joined by Phoenestra in this sponsorship as part of the EVscale™ Partnership, showcasing their joint capabilities and innovation in EV research and development. Don’t miss this opportunity to explore TAmiRNA's latest advancements regarding transcriptomic characterization of EVs. Meet us at the ASEV or reach out to [...]